Skip to search formSkip to main contentSkip to account menu

Chrysalin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rusalatide acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Novel Regenerative Peptide TP508 Mitigates Radiation-Induced Gastrointestinal Damage By Activating Stem Cells and Preserving Crypt Integrity
In recent years, increasing threats of radiation exposure and nuclear disasters have become a significant concern for the United… 
2008
2008
TP508 (Chrysalin®) Reverses Endothelial Dysfunction and Increases Perfusion and Myocardial Function in Hearts With Chronic Ischemia
Endothelial dysfunction (ED) is characterized by impaired nitric oxide (NO) signaling, decreased NO-dependent vasodilatation… 
Review
2008
Review
2008
Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair?
Rusalatide acetate (Chrysalin®) is an investigational drug being evaluated for treatment of chronic wounds and fractures… 
2007
2007
Thrombin peptide Chrysalin® stimulates healing of diabetic foot ulcers in a placebo‐controlled phase I/II study
Thrombin and thrombin peptides play a role in initiating tissue repair. The potential safety and efficacy of TP508 (Chrysalin… 
Review
2006
Review
2006
Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues.
The thrombin peptide, TP508, also known as Chrysalin (OrthoLogic, Tempe, Arizona), is a twenty-three-amino-acid peptide that… 
2005
2005
Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation
A synthetic peptide representing the receptor‐binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates… 
Review
2005
Review
2005
Technology evaluation: Chrysalin (Orthologic).
  • K. Rodgers
  • Current opinion in molecular therapeutics (Print)
  • 2005
  • Corpus ID: 10244816
OrthoLogic (formerly Chrysalis) is developing Chrysalin, a synthetic 23-amino acid peptide that mimics a portion of human… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)